Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.650
+0.040 (1.11%)
At close: Nov 20, 2024, 4:00 PM
3.600
-0.050 (-1.37%)
After-hours: Nov 20, 2024, 7:32 PM EST
Titan Pharmaceuticals Employees
Titan Pharmaceuticals had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$750
Profits / Employee
-$1,365,250
Market Cap
3.34M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Oncternal Therapeutics | 30 |
NovaBay Pharmaceuticals | 26 |
Palisade Bio | 9 |
Enveric Biosciences | 7 |
Virpax Pharmaceuticals | 7 |
TNF Pharmaceuticals | 6 |
Lixte Biotechnology Holdings | 4 |
Quoin Pharmaceuticals | 4 |
TTNP News
- 3 months ago - TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP - Business Wire
- 3 months ago - Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. - GlobeNewsWire
- 10 months ago - Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria - GlobeNewsWire
- 11 months ago - Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets - GlobeNewsWire
- 2 years ago - Titan Pharmaceuticals Provides Shareholder Update - GlobeNewsWire